![Catherine Turkel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Turkel
Directeur/Membre du Conseil chez
Prostate Cancer Research Institute
Profil
Catherine C.
Turkel currently works at Prostate Cancer Research Institute, as Independent Director from 2021.
Dr. Turkel also formerly worked at Cypros Pharmaceutical Corp., as Director-Drug Development & Regulatory Affairs from 1995 to 1998, Object Pharma, Inc., as Independent Director from 2021 to 2023, Lexaria Bioscience Corp., as Independent Director from 2022 to 2025, Allergan, Inc., as Vice President-Clinical Development from 1998 to 2015, Otic Pharma Ltd., as Chief Development Officer from 2015 to 2017, and Eledon Pharmaceuticals, Inc., as President & Head-Research & Development from 2017 to 2020.
Dr. Turkel received her Masters Business Admin degree from the University of California, Irvine, doctorate degree from the University of the Pacific, and doctorate degree from Capella University LLC.
Postes actifs de Catherine Turkel
| Sociétés | Poste | Début |
|---|---|---|
Prostate Cancer Research Institute
 Prostate Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization that helps to research treatment options | Directeur/Membre du Conseil | 01/02/2021 |
Anciens postes connus de Catherine Turkel
| Sociétés | Poste | Fin |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Directeur/Membre du Conseil | 14/01/2025 |
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Directeur/Membre du Conseil | 01/04/2023 |
| ELEDON PHARMACEUTICALS, INC. | President | 30/06/2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Corporate Officer/Principal | 01/01/2017 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/01/2015 |
Formation de Catherine Turkel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cypros Pharmaceutical Corp.
 Cypros Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for the critical care market | Health Technology |
Lexaria Bioscience Corp.
 Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capella University LLC
 Capella University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Prostate Cancer Research Institute
Prostate Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization that helps to research treatment options | Commercial Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Health Technology |
